trefoiltherapeutics.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# Default robots file version:2 User-agent: * Disallow: /calendar/action* Disallow: /events/action* Disallow: /cdn-cgi* Allow: /.css Allow: /.js Disallow: /*? Crawl-delay:

Meta Tags

Title	Trefoil
Description	Recent Trefoil therapeutics Home Page About Us Technology Products For Patients Clinical Trials Patient Resources Treatment Info News News and Events Publicati
Keywords	N/A

Server Information

WebSite	trefoiltherapeutics.com
Host IP	162.241.219.206
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

trefoiltherapeutics.com Valuation

US$9,457,119

Last updated: 2023-05-18 03:23:59

trefoiltherapeutics.com has Semrush global rank of 1,119,189. trefoiltherapeutics.com has an estimated worth of US$ 9,457,119, based on its estimated Ads revenue. trefoiltherapeutics.com receives approximately 1,091,206 unique visitors each day. Its web server is located in United States, with IP address 162.241.219.206. According to SiteAdvisor, trefoiltherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$9,457,119
Daily Ads Revenue	US$8,730
Monthly Ads Revenue	US$261,890
Yearly Ads Revenue	US$3,142,674
Daily Unique Visitors	72,748
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
trefoiltherapeutics.com. 1800	A	trefoiltherapeutics.com. 1800	IP: 162.241.219.206
trefoiltherapeutics.com. 86400	NS	trefoiltherapeutics.com. 86400	NS Record: ns15.wixdns.net.
trefoiltherapeutics.com. 86400	NS	trefoiltherapeutics.com. 86400	NS Record: ns14.wixdns.net.
trefoiltherapeutics.com. 3600	MX	trefoiltherapeutics.com. 3600	MX Record: 10 trefoiltherapeutics-com.mail.protection.outlook.com.
trefoiltherapeutics.com. 3600	TXT	trefoiltherapeutics.com. 3600	TXT Record: v=spf1 a mx include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-18 03:23:59

Trefoil therapeutics Home Page About Us Technology Products For Patients Clinical Trials Patient Resources Treatment Info News News and Events Publications Contact Us Restoration Through Regeneration We are dedicated to restoring sight to the millions of people who live with corneal diseases through the advancement of regenerative therapies. One Molecule. Two Products. Multiple Potential Indications. Trefoil is advancing two products based on TTHX1114 to treat a spectrum of corneal diseases affecting the back or the front of the cornea. The company’s lead investigational medicine, TTHX1114, is an investigational engineered form of Fibroblast Growth Factor (FGF-1) that has the potential to be first-in-class and is being studied for the treatment of corneal endothelial dystrophies and conditions via intracameral injection. A topical formulation of the product is also under development for the treatment of multiple epithelial indications where corneal ulcerations are present. NEWS: Our

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 11 May 2022 08:22:39 GMT
Server: Apache
Strict-Transport-Security: max-age=31536000
Permissions-Policy: geolocation=(),midi=(),sync-xhr=(),microphone=(),camera=(),magnetometer=(),gyroscope=(),fullscreen=(self),payment=()
Content-Security-Policy: upgrade-insecure-requests
Expect-CT: max-age=7776000, enforce
Location: https://trefoiltherapeutics.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 301 
x-redirect-by: WordPress
strict-transport-security: max-age=31536000
permissions-policy: geolocation=(),midi=(),sync-xhr=(),microphone=(),camera=(),magnetometer=(),gyroscope=(),fullscreen=(self),payment=()
content-security-policy: upgrade-insecure-requests
expect-ct: max-age=7776000, enforce
location: https://www.trefoiltherapeutics.com/
host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ==
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
referrer-policy: same-origin
x-xss-protection: 1; mode=block
content-type: text/html; charset=UTF-8
date: Wed, 11 May 2022 08:22:40 GMT
server: Apache

HTTP/2 200 
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
strict-transport-security: max-age=31536000
permissions-policy: geolocation=(),midi=(),sync-xhr=(),microphone=(),camera=(),magnetometer=(),gyroscope=(),fullscreen=(self),payment=()
content-security-policy: upgrade-insecure-requests
expect-ct: max-age=7776000, enforce
host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ==
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
referrer-policy: same-origin
x-xss-protection: 1; mode=block
content-type: text/html; charset=UTF-8
date: Wed, 11 May 2022 08:22:41 GMT
server: Apache

trefoiltherapeutics.com Whois Information

Domain Name: TREFOILTHERAPEUTICS.COM
Registry Domain ID: 1824420717_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-07-31T14:06:45Z
Creation Date: 2013-08-30T16:01:08Z
Registry Expiry Date: 2024-08-30T16:01:08Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS14.WIXDNS.NET
Name Server: NS15.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-11T09:22:32Z <<<

trefoiltherapeutics.com valuation and analysis